Appendicectomy versus antibiotics for acute uncomplicated appendicitis in children: an open-label, international, multicentre, randomised, non-inferiority trial Lancet. 2025;405(10474):233-240 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39826968
Chronic Hepatitis B in Which HBs Antigen Seroclearance Was Induced by Pegpegylated-interferonα-2a after Hepatocellular Carcinoma Treatment with Nucleos(t)ide Analogues: A Five-year Follow-up Internal Medicine. 2025;64(2):225-229 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38811223
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study Lancet. 2025;405(10474):216-232 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39798579
Eradication Therapy to Prevent Gastric Cancer in H. pylori-positive individuals: Systematic Review and Meta-analysis of Randomized Controlled Trials and Observational Studies Gastroenterology - 15 January 2025 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39824392
Multiple Ulcers with Perforations of the Small Intestine in the Acute Phase of CD19 Chimeric Antigen Receptor T-cell Therapy Possibly Associated with Tocilizumab Administration Internal Medicine. 2025;64(3):435-438 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39894508
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial Lancet. 2025;405(10476):383-395 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39874977
Six-fold increased risk of acute pancreatitis in alcohol-related liver disease compared to matched comparators: A population-based cohort study Journal of Internal Medicine. 2025;297(2):213-226 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39655576
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study Lancet. 2025;405(10474):203-215 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39798578
Unusual Presentation of Double-seronegative Myasthenia Gravis with Positive Anti-LRP4 Antibody: Diagnostic Utility of a Videofluoroscopic Swallowing Study Internal Medicine. 2025;64(2):307-311 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38897960
Acute Severe Colitis after mRNA Coronavirus Disease 2019 Vaccination Internal Medicine. 2025;64(2):201-207
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39523001
Adenoma Detection Rates by Physicians and Subsequent Colorectal Cancer Risk JAMA. 2025;333(5):400-407
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39680377
Appendicectomy versus antibiotics for acute uncomplicated appendicitis in children: an open-label, international, multicentre, randomised, non-inferiority trial Lancet. 2025;405(10474):233-240
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39826968
The association between vitamin C and breast cancer, prostate cancer and colorectal cancer: A systematic review and meta-analysis Clin Nutr ESPEN. 2025;65:400-407
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39657872
Autoimmune Hepatitis with Metabolic Dysfunction-associated Fatty Liver Disease Internal Medicine. 2025;64(3):337-342
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38960681
Characteristics of Early Gastric Cancer in a Patient with a History of Helicobacter pylori Infection and No History of Eradication Therapy Internal Medicine. 2025;64(3):343-350
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38960692
Chronic Hepatitis B in Which HBs Antigen Seroclearance Was Induced by Pegpegylated-interferonα-2a after Hepatocellular Carcinoma Treatment with Nucleos(t)ide Analogues: A Five-year Follow-up Internal Medicine. 2025;64(2):225-229
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38811223
Comparison of the Consequences of Short- Versus Long-Term Intubation on Speech and Swallowing American Journal of Physical Medicine and Rehabilitation. 2025;104(2):127-129
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39477224
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study Lancet. 2025;405(10474):216-232
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39798579
Ectopic Adrenocorticotropic Hormone Syndrome due to Pancreatic Neuroendocrine Carcinoma Internal Medicine. 2025;64(2):237-242
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38811222
Eradication Therapy to Prevent Gastric Cancer in H. pylori-positive individuals: Systematic Review and Meta-analysis of Randomized Controlled Trials and Observational Studies Gastroenterology - 15 January 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39824392
Gastric Adenocarcinoma with Enteroblastic Differentiation which Demonstrated Rapid Progressive Courses Internal Medicine. 2025;64(3):381-386
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38925967
HepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse: The BEe-HIVe Randomized Clinical Trial JAMA. 2025;333(4):295-306
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39616603
Metabolic Dysfunction-Associated Steatotic Liver Disease Annals of Internal Medicine. 2025;178(1):Itc1-itc16
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39805112
Multiple Ulcers with Perforations of the Small Intestine in the Acute Phase of CD19 Chimeric Antigen Receptor T-cell Therapy Possibly Associated with Tocilizumab Administration Internal Medicine. 2025;64(3):435-438
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39894508
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial Lancet. 2025;405(10476):383-395
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39874977
Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer New England Journal of Medicine. 2025;392(4):323-335
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39842010
Postoperative Ileus and Nonpharmacological Nursing Interventions for Colorectal Surgery: A Systematic Review Journal of Perianesthesia Nursing. 2025;40(1):181-194
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38970591
Secondary Growth Hormone Deficiency That Developed into Cirrhosis after Several Years of Interrupted Growth Hormone Replacement Therapy Internal Medicine. 2025;64(3):387-391
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38925969
Six-fold increased risk of acute pancreatitis in alcohol-related liver disease compared to matched comparators: A population-based cohort study Journal of Internal Medicine. 2025;297(2):213-226
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39655576
Systematic review of survival following liver or lung metastasectomy for metastatic anal squamous cell carcinoma Annals of the Royal College of Surgeons of England. 2025;107(2):92-97
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38497793
Tenofovir and Hepatitis B Virus Transmission During Pregnancy: A Randomized Clinical Trial JAMA. 2025;333(5):390-399
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39540799
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study Lancet. 2025;405(10474):203-215
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39798578
Unusual Presentation of Double-seronegative Myasthenia Gravis with Positive Anti-LRP4 Antibody: Diagnostic Utility of a Videofluoroscopic Swallowing Study Internal Medicine. 2025;64(2):307-311
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38897960
Wilson's Disease Suspected to Involve a Novel Genetic Mutation of ATP7B Gene, Requiring a Differential Diagnosis with Non-alcoholic Steatohepatitis Internal Medicine. 2025;64(3):375-379
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38960689
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B New England Journal of Medicine. 2024;391(22):2098-2109
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39774313